A prospective analysis using plasma proteomics in UK Biobank maps measurable biological shifts years before clinical age-related macular degeneration diagnosis. Across 45,379 participants followed a median of 15.2 years, the study reports 92 proteins associated with incident disease and identifies a proteomic trajectory inflection about 8.81 years prior to diagnosis; NECTIN2 emerges as a convergent candidate across analyses.